Discussion

JAMA Internal Medicine

Volumn 176, Issue 2, 2016, Pages 259-261

  Chen, Jonathan H ^a,b   Humphreys, Keith ^a,b   Shah, Nigam H ^c   Lembke, Anna ^b  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHINE; NARCOTIC ANALGESIC AGENT;

ANESTHESIA; BILLING AND CLAIMS; CLINICAL PRACTICE; DRUG FORMULATION; HUMAN; LETTER; MEDICAL SPECIALIST; MEDICARE; PAIN; PRESCRIPTION; PRIORITY JOURNAL; INAPPROPRIATE PRESCRIBING; UNITED STATES;

ANALGESICS, OPIOID; HUMANS; INAPPROPRIATE PRESCRIBING; MEDICARE; PRACTICE PATTERNS, PHYSICIANS'; UNITED STATES;

EID: 84957955646     PISSN: 21686106     EISSN: 21686114     Source Type: Journal    
DOI: 10.1001/jamainternmed.2015.6662     Document Type: Letter

References (6)

1. Jones CM, Mack KA, Paulozzi LJ. Pharmaceutical overdose deaths, United States, 2010. JAMA. 2013;309(7):657-659.
2. Rosenau AM. Guidelines for opioid prescription: The devil is in the details. Ann Intern Med. 2013;158(11):843-844.
3. BetsesM, Brennan T. Abusive prescribing of controlled substances: A pharmacy view. N Engl J Med. 2013;369(11):989-991.
4. Ireland J. Johnson G. Prescribing patterns of schedule II opioids in CaliforniaWorkers Compensation. 2011. http://www.cwci.org/document.php ?file=1438.pdf. Accessed November 5, 2015.
5. Centers for Medicare and Medicaid Services. Medicare Provider Utilization and Payment Data. Part D Prescriber. 2015. http://www.cms.gov/Research-Statistics-Data-And-Systems/Statistics-Trends-And-Reports/Medicare-Provider-Charge-Data/Part-D-Prescriber.html. Accessed November 5, 2015.
6. ReedWJ. The Pareto, Zipf, and other power laws. Econ Lett. 2001;74(1):15-19. doi:10.1016/S0165-1765(01)00524-9.